These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9136504)

  • 1. Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.
    McDougle CJ; Holmes JP; Bronson MR; Anderson GM; Volkmar FR; Price LH; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):685-93. PubMed ID: 9136504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open trial of risperidone in 24 young children with pervasive developmental disorders.
    Masi G; Cosenza A; Mucci M; Brovedani P
    J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1206-14. PubMed ID: 11589534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.
    Lombroso PJ; Scahill L; King RA; Lynch KA; Chappell PB; Peterson BS; McDougle CJ; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1147-52. PubMed ID: 7559308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case series: use of ziprasidone for maladaptive symptoms in youths with autism.
    McDougle CJ; Kem DL; Posey DJ
    J Am Acad Child Adolesc Psychiatry; 2002 Aug; 41(8):921-7. PubMed ID: 12164181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label second generation antipsychotics for impulse regulation disorders: a review.
    Scheltema Beduin A; de Haan L
    Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
    Turgay A; Binder C; Snyder R; Fisman S
    Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone in children and adolescents with pervasive developmental disorder: pilot trial and follow-up.
    Perry R; Pataki C; Munoz-Silva DM; Armenteros J; Silva RR
    J Child Adolesc Psychopharmacol; 1997; 7(3):167-79. PubMed ID: 9466234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open trial of risperidone in young autistic children.
    Nicolson R; Awad G; Sloman L
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):372-6. PubMed ID: 9549957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V
    Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.
    Arnold LE; Vitiello B; McDougle C; Scahill L; Shah B; Gonzalez NM; Chuang S; Davies M; Hollway J; Aman MG; Cronin P; Koenig K; Kohn AE; McMahon DJ; Tierney E
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1443-50. PubMed ID: 14627879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study.
    Capone GT; Goyal P; Grados M; Smith B; Kammann H
    J Dev Behav Pediatr; 2008 Apr; 29(2):106-16. PubMed ID: 18349709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching to aripiprazole in subjects with pervasive developmental disorders showing tolerability issues with risperidone.
    Ishitobi M; Hiratani M; Kosaka H; Takahashi T; Mizuno T; Asano M; Murata T; Tomoda A; Wada Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):128-31. PubMed ID: 22245026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone in adolescents with schizophrenia: an open pilot study.
    Armenteros JL; Whitaker AH; Welikson M; Stedge DJ; Gorman J
    J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):694-700. PubMed ID: 9136505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
    de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
    Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
    McDougle CJ; Holmes JP; Carlson DC; Pelton GH; Cohen DJ; Price LH
    Arch Gen Psychiatry; 1998 Jul; 55(7):633-41. PubMed ID: 9672054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.